FUS Immunogold Labeling TEM Analysis of the Neuronal Cytoplasmic Inclusions of Neuronal Intermediate Filament Inclusion Disease: A Frontotemporal Lobar Degeneration with FUS Proteinopathy
Open Access
- 21 May 2011
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 45 (3) , 409-421
Abstract
Fused in sarcoma (FUS)-immunoreactive neuronal and glial inclusions define a novel molecular pathology called FUS proteinopathy. FUS has been shown to be a component of inclusions of familial amyotrophic lateral sclerosis with FUS mutation and three frontotemporal lobar degeneration entities, including neuronal intermediate filament inclusion disease (NIFID). The pathogenic role of FUS is unknown. In addition to FUS, many neuronal cytoplasmic inclusions (NCI) of NIFID contain aggregates of α-internexin and neurofilament proteins. Herein, we have shown that: (1) FUS becomes relatively insoluble in NIFID and there are no apparent posttranslational modifications, (2) there are no pathogenic abnormalities in the FUS gene in NIFID, and (3) immunoelectron microscopy demonstrates the fine structural localization of FUS in NIFID which has not previously been described. FUS localized to euchromatin, and strongly with paraspeckles, in nuclei, consistent with its RNA/DNA-binding functions. NCI of varying morphologies were observed. Most frequent were the “loosely aggregated cytoplasmic inclusions,” 81% of which had moderate or high levels of FUS immunoreactivity. Much rarer “compact cytoplasmic inclusions” and “tangled twine ball inclusions” were FUS-immunoreactive at their granular peripheries, or heavily FUS-positive throughout, respectively. Thus, FUS may aggregate in the cytoplasm and then admix with neuronal intermediate filament accumulations.Keywords
This publication has 54 references indexed in Scilit:
- Gigaxonin mutation analysis in patients with NIFIDNeurobiology of Aging, 2011
- The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion diseaseActa Neuropathologica, 2010
- Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an updateActa Neuropathologica, 2009
- Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion diseaseActa Neuropathologica, 2009
- TARDBP 3′-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathyActa Neuropathologica, 2009
- Rethinking ALS: The FUS about TDP-43Cell, 2009
- Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathyJournal of Neural Transmission, 2008
- Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcriptionNature, 2008
- TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisThe Lancet Neurology, 2008
- TDP‐43 A315T mutation in familial motor neuron diseaseAnnals of Neurology, 2008